
Oxford Nanopore Technologies
Associate Director, Regional Marketing DACH & Channel Partners
About Oxford Nanopore Technologies
Oxford Nanopore Technologies is a pioneering biotechnology company developing DNA and RNA sequencing technology that enables real-time analysis at any scale, from portable devices to population-scale studies. Our mission is to enable the analysis of any living thing, by anyone, anywhere.
The Opportunity
We are seeking an experienced Associate Director, Regional Marketing DACH & Channel Partners to lead the development, execution, and optimisation of regional marketing strategies across the DACH region and the EMEAI Channel Partner network.
Working closely with commercial, product and global marketing teams, you will drive go-to-market initiatives, demand generation programmes, customer engagement activities and sales enablement efforts that support regional growth objectives and revenue targets.
Key Responsibilities
Regional Marketing Strategy
Marketing Campaigns
Commercial Enablement
About You
The ideal candidate will bring:
Why Oxford Nanopore?
This is an opportunity to join a company at the forefront of scientific innovation and play a key role in expanding the adoption of transformative sequencing technology across global markets.
Apply today to help shape the future of genomics.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability, or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-remote
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.